Thyroid Ablation Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, Application, End-use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Thyroid Ablation Devices Market size was over USD 219.8 million in 2026 and is likely to grow at a 9.12% CAGR between 2027 and 2036, reaching USD 526.1 million by 2036. The industry revenue for 2027 is estimated at USD 236.68 million.
Get more details on this report
Request Free Sample ReportThyroid Ablation Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 37.42% share in 2026, supported by established image-guided treatment pathways, broad specialist expertise, and strong adoption of minimally invasive thyroid procedures.
- Asia Pacific is projected to expand at a 10.96% CAGR as healthcare infrastructure improves, ultrasound-guided procedures gain wider adoption, and demand rises for minimally invasive thyroid treatments.
Segment Momentum
- Thermal Based Devices accounted for 67.9% of the market in 2026 due to established procedural familiarity, consistent lesion creation, and widespread integration into thyroid ablation workflows across clinical settings.
- Thyroid Nodules are the fastest-growing application as clinicians increasingly adopt minimally invasive treatments for symptomatic or clinically relevant nodules, expanding procedural use beyond traditional surgical approaches.
Market Expansion Drivers
- Rising incidence of thyroid cancer and nodules increasing demand for minimally invasive ablation treatments.
- Integration of AI and robotic-assisted systems improving procedural precision and outcomes.
- Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden.
Leading Market Participants
- Major companies in the thyroid ablation devices market include Medtronic plc (Ireland), Boston Scientific Corporation (United States), Olympus Corporation (Japan), Johnson & Johnson (United States), Integra LifeSciences Holdings Corporation (United States), Terumo Corporation (Japan), Theraclion SA (France), STARmed Co., Ltd. (South Korea), MedWaves, Inc. (United States), BVM Medical Limited (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 219.8 million
- 2027 Estimated Market Size: USD 236.68 million.
- Projected Market Size: USD 526.1 million by 2036
- Growth Forecast: 9.12% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Thermal Based Devices (Product) | Thyroid Cancer (Application) | Hospitals (End-use) | Radiofrequency Ablation (Type)
- Emerging Opportunity Segment: Non-Thermal Based Devices (Product) | Thyroid Nodules (Application) | Ambulatory Surgical Centers (End-use) | Microwave Ablation (Type)
Market Growth Drivers and Industry Trends
Rising incidence of thyroid cancer and nodules increasing demand for minimally invasive ablation treatments
The increasing prevalence of thyroid nodules and thyroid cancer is creating a larger pool of patients requiring effective treatment options, while thyroid ablation devices market growth is supported by the rising interest in minimally invasive alternatives. Ablation techniques can target abnormal thyroid tissue through image-guided procedures while limiting the tissue disruption associated with conventional surgery. Growing clinical interest in preserving thyroid function, reducing visible scarring, and shortening procedural recovery is encouraging healthcare providers to consider ablation for appropriately selected patients, particularly where treatment objectives can be achieved without extensive surgical intervention.
Integration of AI and robotic-assisted systems improving procedural precision and outcomes
Technological advances are enhancing the accuracy and control of image-guided thyroid interventions, with the integration of artificial intelligence and robotic-assisted capabilities contributing to thyroid ablation devices market growth. AI-supported imaging and procedural guidance can assist clinicians in identifying treatment areas, assessing anatomical structures, and maintaining more consistent targeting during ablation, while robotic technologies can improve instrument positioning and operator control. These capabilities are particularly relevant for procedures where accurate energy delivery and protection of surrounding tissues are important considerations, encouraging healthcare facilities to adopt increasingly sophisticated ablation platforms.
Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden
A growing preference for procedures that can be performed with less hospitalization, limited tissue trauma, and faster recovery is increasing the appeal of minimally invasive thyroid interventions and supporting thyroid ablation devices market demand. Compared with more extensive surgical approaches, outpatient ablation can reduce the physical burden associated with treatment and may allow suitable patients to return to routine activities more quickly. Healthcare providers are also attracted to treatment pathways that can improve resource utilization and reduce the need for prolonged postoperative care, particularly as patients increasingly value less invasive procedures with fewer visible treatment effects.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of thyroid cancer and nodules increasing demand for minimally invasive ablation treatments | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| Integration of AI and robotic-assisted systems improving procedural precision and outcomes | 2.00% | High | North America, Europe | Medium | Mid Term |
| Preference shift toward outpatient minimally invasive thyroid procedures reducing surgical burden | 1.50% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the thyroid ablation devices market, North America accounted for a 37.42% share in 2026, reflecting advanced healthcare infrastructure, strong adoption of minimally invasive treatment approaches, and growing clinical interest in alternatives to conventional thyroid surgery. The region benefits from specialized endocrinology and interventional care networks, established physician expertise, and patient demand for procedures associated with reduced invasiveness and shorter recovery periods. Continued improvements in image-guided technologies and treatment precision are also supporting adoption. Increasing recognition of thyroid nodules and broader use of minimally invasive interventions are contributing to sustained demand for ablation-based treatment options.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market as healthcare infrastructure expands and awareness of minimally invasive thyroid treatments increases. Growing investments in advanced diagnostic and interventional facilities are improving access to image-guided procedures, particularly in major urban healthcare centers. Rising patient volumes associated with thyroid disorders, combined with increasing physician familiarity with ablation techniques, are creating a favorable environment for technology adoption. Improvements in healthcare affordability and the expansion of specialized medical services are further supporting demand, while greater emphasis on procedures that can reduce surgical burden is strengthening the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Treatment IntegrationGermany emphasizes clinically validated thyroid ablation devices supported by advanced imaging and standardized treatment protocols. German hospitals continue integrating minimally invasive solutions that improve procedural accuracy and patient outcomes.
France 🇫🇷
Clinical Practice ExpansionFrance is incorporating thyroid ablation devices into endocrine treatment pathways for carefully selected patients seeking non-surgical interventions. Hospitals increasingly emphasize physician training and consistent procedural standards to support broader clinical adoption.
Italy 🇮🇹
Outpatient Treatment GrowthItaly is expanding the use of thyroid ablation devices in outpatient settings where minimally invasive procedures can improve patient convenience. Healthcare facilities prioritize reliable technologies that support accurate treatment planning and streamlined recovery.
Japan 🇯🇵
Image-Guided Care FocusJapan is strengthening the use of thyroid ablation devices within specialized endocrine care, supported by demand for less invasive therapeutic options. Japanese clinicians prioritize precise image-guided interventions that preserve healthy thyroid tissue whenever appropriate.
South Korea 🇰🇷
Technology-Driven ProceduresSouth Korea continues advancing thyroid ablation device adoption through experienced specialists and strong utilization of ultrasound-guided therapies. Healthcare providers focus on expanding minimally invasive treatment options while improving procedural efficiency.
United States 🇺🇸
Minimally Invasive AdoptionThe U.S. thyroid ablation devices market is expanding through wider adoption of minimally invasive procedures for benign thyroid nodules. Healthcare providers increasingly invest in image-guided technologies that reduce recovery time while offering alternatives to conventional surgery.
Segment Leadership and Growth Trends
Thyroid Ablation Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Thermal Based Devices (Largest Segment) vs Non-Thermal Based Devices (Fastest-Growing Segment)
Thermal based devices held the largest share of the thyroid ablation devices market, representing 67.9% in 2026, owing to their established role in minimally invasive treatment of thyroid lesions and nodules. These technologies use controlled thermal energy to destroy targeted tissue while limiting damage to surrounding structures, making them attractive alternatives to more invasive procedures in appropriate cases. Increasing preference for minimally invasive interventions, improved procedural precision, and growing clinical familiarity with thermal ablation continue to support the segment's leading position.
Non-thermal based devices are advancing more rapidly as clinical interest grows in ablation approaches that can minimize heat-related effects on surrounding tissues. These technologies offer alternative mechanisms for targeted tissue destruction and may be particularly relevant where preservation of adjacent structures is an important consideration. Continued innovation in minimally invasive thyroid treatment, together with demand for precise interventions and improved procedural safety, is supporting increasing attention toward non-thermal approaches.
Application Segment Analysis: Thyroid Cancer (Largest Segment) vs Thyroid Nodules (Fastest-Growing Segment)
Thyroid cancer represented the largest application segment in the thyroid ablation devices market, accounting for 64.99% in 2026, supported by the growing role of minimally invasive technologies in the management of selected thyroid malignancies. Ablation approaches can provide targeted treatment options for appropriate patients while potentially reducing the need for more extensive surgical intervention. Increasing emphasis on localized therapies, precision treatment, and patient-centered care is reinforcing the application of ablation technologies in thyroid cancer management.
Thyroid nodules are experiencing faster growth as improved diagnostic imaging increases the identification and monitoring of benign and potentially problematic nodules. For appropriately selected patients, ablation can offer a minimally invasive option aimed at reducing nodule volume and associated symptoms while preserving thyroid tissue. Greater awareness of alternatives to conventional surgery, combined with advances in image-guided procedures and growing preference for less invasive treatment pathways, is supporting stronger adoption in thyroid nodule applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Thermal Based Devices, Non-Thermal Based Devices | Thermal Based Devices | Non-Thermal Based Devices |
| Application | Thyroid Cancer, Thyroid Nodules | Thyroid Cancer | Thyroid Nodules |
| End-use | Hospitals, Ambulatory Surgical Centers, Cancer Specialty Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Type | Radiofrequency Ablation, Microwave Ablation, Others | Radiofrequency Ablation | Microwave Ablation |
Competitive Landscape and Market Positioning
Top players in the thyroid ablation devices market:
1. Medtronic plc (Ireland)
2. Boston Scientific Corporation (United States)
3. Olympus Corporation (Japan)
4. Johnson & Johnson (United States)
5. Integra LifeSciences Holdings Corporation (United States)
6. Terumo Corporation (Japan)
7. Theraclion SA (France)
8. STARmed Co. Ltd. (South Korea)
9. MedWaves Inc. (United States)
10. BVM Medical Limited (United Kingdom)
The thyroid ablation devices market is advancing through improvements in minimally invasive treatment technologies. Innovation focuses on enhancing precision targeting and procedural safety. The thyroid ablation devices market is also influenced by increasing demand for non-surgical treatment alternatives. Continuous device refinement is improving clinical efficiency and outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Olympus Corporation (Japan) | |||||||
| Johnson & Johnson (United States) | |||||||
| Integra LifeSciences Holdings Corporation (United States) | |||||||
| Terumo Corporation (Japan) | |||||||
| Theraclion SA (France) | |||||||
| STARmed Co. Ltd. (South Korea) | |||||||
| MedWaves Inc. (United States) | |||||||
| BVM Medical Limited (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Baird Medical | Mar-24 | Baird Medical obtained NMPA Class III approval for its radiofrequency ablation system in March 2024, marking regulatory clearance for thyroid indications. The approval strengthened competitive positioning in China and contributed to pricing pressure across imported ablation devices. |
| PIUR Imaging | Feb-24 | PIUR Imaging launched the tUS Infinity AI-enabled 3D ultrasound platform in February 2024. The system improves procedural efficiency in thyroid ablation workflows by enhancing imaging precision and reducing treatment time while supporting improved lesion volume reduction outcomes. |
| Hygea | Jan-24 | Hygea received U.S. FDA 510(k) clearance in January 2024 for its microwave ablation platform. The approval expands available energy-based treatment options for thyroid interventions and supports broader clinical adoption in minimally invasive ablation procedures. |
| STARmed Co., Ltd. | Aug-23 | STARmed established STARmed America in August 2023 to expand its direct presence in the U.S. market. The subsidiary enhances commercial reach and supports distribution and clinical collaboration for its thermal ablation technologies in North America. |
| Baird Medical | Jul-23 | Baird Medical received China NMPA Class III approval in July 2023 for its microwave ablation disposable needle used in thyroid nodule treatment. The clearance strengthens its regulatory position in energy-based thyroid ablation technologies and supports domestic commercialization. |
| Boston Scientific Corporation | Dec-22 | Boston Scientific acquired a majority stake in Acotec Scientific Holdings in December 2022. The acquisition expands its interventional portfolio, including access to radiofrequency ablation technologies and related minimally invasive therapeutic device capabilities. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Thyroid Ablation Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Imaging Guidance Modality | Ultrasound-Guided, CT-Guided, MRI-Guided, Other Imaging-Guided Procedures |
| Patient Age Group | Pediatric, Adult, Geriatric |
| Route to Market | Direct Sales, Distributor Sales, Group Purchasing Organizations |
Thyroid Ablation Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Reimbursement and Market Access Strategy |
|
| Clinical Adoption and Procedure Growth |
|
| Hospital Procurement and Purchasing Dynamics |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the thyroid ablation devices market?
How much is the thyroid ablation devices industry expected to grow by 2036?
How is the shift toward minimally invasive thyroid treatments affecting market adoption of ablation devices?
How are AI and robotic-assisted technologies improving procedural adoption in thyroid ablation procedures?
Why do Thermal Based Devices lead the thyroid ablation devices market?
Why are Thyroid Nodules the fastest-growing application in the thyroid ablation devices market?
Why is North America the leading region in the thyroid ablation devices market?
What is driving rapid growth in the thyroid ablation devices market across Asia Pacific?
Who are the leading players in the thyroid ablation devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization